Astellas Pharma Inc.

Company NameAstellas Pharma Inc.
Executive 1Masafumi Nogimori, Chairman; President; Senior Managing Director
Revenue (Millions)$11,255
Total Equity (Millions)$13,387
Net Income (Millions)$908
Revenue Growth1.62%
Profit Margin 18.07%
Earnings per Share$1.96
Debt to Equity RatioN/A
Return on Equity6.91%
Cost of Goods Sold (Millions)$3,699
Earnings per Share Growth15.61%
Total Assets (Millions)$16,262
Current Liabilities (Millions)$4,441
Long Term Debt (Millions)N/A